179 related articles for article (PubMed ID: 16580204)
1. Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism.
Simoni D; Roberti M; Invidiata FP; Aiello E; Aiello S; Marchetti P; Baruchello R; Eleopra M; Di Cristina A; Grimaudo S; Gebbia N; Crosta L; Dieli F; Tolomeo M
Bioorg Med Chem Lett; 2006 Jun; 16(12):3245-8. PubMed ID: 16580204
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
Roberti M; Pizzirani D; Simoni D; Rondanin R; Baruchello R; Bonora C; Buscemi F; Grimaudo S; Tolomeo M
J Med Chem; 2003 Jul; 46(16):3546-54. PubMed ID: 12877593
[TBL] [Abstract][Full Text] [Related]
3. 3,4,4'-Trihydroxy-trans-stilbene, an analogue of resveratrol, is a potent antioxidant and cytotoxic agent.
Cai W; Zhang L; Song Y; Zhang B; Cui X; Hu G; Fang J
Free Radic Res; 2011 Nov; 45(11-12):1379-87. PubMed ID: 21974738
[TBL] [Abstract][Full Text] [Related]
4. Finding more active antioxidants and cancer chemoprevention agents by elongating the conjugated links of resveratrol.
Tang JJ; Fan GJ; Dai F; Ding DJ; Wang Q; Lu DL; Li RR; Li XZ; Hu LM; Jin XL; Zhou B
Free Radic Biol Med; 2011 May; 50(10):1447-57. PubMed ID: 21376113
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity.
Naini R; Ravikumar E; Singh SS; Kancha RK; Rao KV; Reddy VD
Anticancer Agents Med Chem; 2017 Nov; 17(11):1537-1544. PubMed ID: 28356012
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells.
Minutolo F; Sala G; Bagnacani A; Bertini S; Carboni I; Placanica G; Prota G; Rapposelli S; Sacchi N; Macchia M; Ghidoni R
J Med Chem; 2005 Nov; 48(22):6783-6. PubMed ID: 16250636
[TBL] [Abstract][Full Text] [Related]
7. Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action.
Scherzberg MC; Kiehl A; Zivkovic A; Stark H; Stein J; Fürst R; Steinhilber D; Ulrich-Rückert S
Toxicol Appl Pharmacol; 2015 Aug; 287(1):67-76. PubMed ID: 26044878
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic evaluation of a series of resveratrol derivatives modified in C2 position.
Huang XF; Ruan BF; Wang XT; Xu C; Ge HM; Zhu HL; Tan RX
Eur J Med Chem; 2007 Feb; 42(2):263-7. PubMed ID: 17000031
[TBL] [Abstract][Full Text] [Related]
9. Cis-stilbene derived furopyranones show potent antiproliferative activity by inducing G2/M arrest.
Fuhrer CA; Grüter E; Ruetz S; Häner R
ChemMedChem; 2007 Apr; 2(4):441-4. PubMed ID: 17323400
[No Abstract] [Full Text] [Related]
10. The resveratrol analogue 4,4'-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol.
Savio M; Coppa T; Bianchi L; Vannini V; Maga G; Forti L; Cazzalini O; Lazzè MC; Perucca P; Prosperi E; Stivala LA
Int J Biochem Cell Biol; 2009 Dec; 41(12):2493-502. PubMed ID: 19679195
[TBL] [Abstract][Full Text] [Related]
11. Effects of hydroxylated resveratrol analogs on oxidative stress and cancer cells death in human acute T cell leukemia cell line: prooxidative potential of hydroxylated resveratrol analogs.
Kucinska M; Piotrowska H; Luczak MW; Mikula-Pietrasik J; Ksiazek K; Wozniak M; Wierzchowski M; Dudka J; Jäger W; Murias M
Chem Biol Interact; 2014 Feb; 209():96-110. PubMed ID: 24398169
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel stilbene-based antitumor agents.
Simoni D; Invidiata FP; Eleopra M; Marchetti P; Rondanin R; Baruchello R; Grisolia G; Tripathi A; Kellogg GE; Durrant D; Lee RM
Bioorg Med Chem; 2009 Jan; 17(2):512-22. PubMed ID: 19117761
[TBL] [Abstract][Full Text] [Related]
13. Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.
Roberti M; Pizzirani D; Recanatini M; Simoni D; Grimaudo S; Di Cristina A; Abbadessa V; Gebbia N; Tolomeo M
J Med Chem; 2006 May; 49(10):3012-8. PubMed ID: 16686543
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structural characterisation and biological evaluation of fluorinated analogues of resveratrol.
Moran BW; Anderson FP; Devery A; Cloonan S; Butler WE; Varughese S; Draper SM; Kenny PT
Bioorg Med Chem; 2009 Jul; 17(13):4510-22. PubMed ID: 19481462
[TBL] [Abstract][Full Text] [Related]
15. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines.
Simoni D; Grisolia G; Giannini G; Roberti M; Rondanin R; Piccagli L; Baruchello R; Rossi M; Romagnoli R; Invidiata FP; Grimaudo S; Jung MK; Hamel E; Gebbia N; Crosta L; Abbadessa V; Di Cristina A; Dusonchet L; Meli M; Tolomeo M
J Med Chem; 2005 Feb; 48(3):723-36. PubMed ID: 15689156
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271
[TBL] [Abstract][Full Text] [Related]
17. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
18. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents.
Kumar AS; Reddy MA; Jain N; Kishor C; Murthy TR; Ramesh D; Supriya B; Addlagatta A; Kalivendi SV; Sreedhar B
Eur J Med Chem; 2013 Feb; 60():305-24. PubMed ID: 23313639
[TBL] [Abstract][Full Text] [Related]
20. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
